Retatrutide 20mg Research Peptide
A triple-receptor agonist studied in metabolic and energy-balance research.
Select Strength
For Research Use Only
What is Retatrutide?
Retatrutide is an investigational peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon — and is studied in clinical research for metabolic regulation and body composition.
- Research Category
- Metabolic
- Form
- Lyophilized peptide
- CAS Number
- 2381089-83-2
- Purity
- >99%
- Origin
- USA
- Intended Use
- Laboratory Research
Retatrutide at a Glance
Retatrutide Research
Retatrutide is an investigational triple-hormone-receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. It has been studied in clinical research for its effects on metabolic regulation and body composition.
Because it engages three distinct metabolic pathways, it has attracted research interest into how combined incretin and glucagon receptor activity may influence energy balance. Human clinical trials have reported outcomes related to body composition and metabolic markers.
Retatrutide remains an investigational compound. It is not approved as a treatment, and these research materials are sold for laboratory research use only.
What is Retatrutide being studied for?
Metabolic Regulation
Studied in clinical research for effects on metabolic regulation and energy balance.
ExploreBody Composition Research
Clinical research has examined body composition outcomes.
ExploreHealthy Aging
Explored in the context of metabolic factors relevant to aging research.
ExploreHow is Retatrutide studied?
Retatrutide is characterized as an agonist at three receptors relevant to metabolic signaling.
Retatrutide
Triple-receptor agonist
GLP-1 / GIP / Glucagon
Three receptor targets
Metabolic Signaling
Energy and glucose pathways
Research Area
Metabolic
Receptor activity is established; translation of this activity into specific human outcomes is the subject of ongoing clinical research.
Understanding the Retatrutide Research
In Vitro
Receptor activity has been characterized in laboratory studies.
Preclinical
Animal-model studies have examined metabolic and body composition effects.
Human Research
Human clinical trials have reported outcomes related to body composition and metabolic markers.
Regulatory Status
Retatrutide is an investigational compound, not approved by the FDA as a treatment. Sold for research use only.
Research starts with quality.
BioAura compounds are produced in the USA with batch-specific analytical testing. Every detail is built around a higher standard — from synthesis and purification to documented verification.
Know what you're researching.
Identity
Confirms the compound matches its expected structure.
Retatrutide Storage & Handling
Lyophilized Storage
Store lyophilized peptide at room temperature away from UV light
Temperature
Store at 65–75°F when lyophilized
Light Exposure
Protect from prolonged light exposure
Reconstituted
Store refrigerated at 36–42°F
For laboratory research handling only. Not human dosing or clinical guidance.
Continue exploring.
This product is sold for research use only and is not intended for human consumption, medical diagnosis, or treatment. These products have not been evaluated by the FDA. Statements are for research and educational purposes and do not constitute medical advice. BioAura does not make disease-treatment, therapeutic, or human-use claims.